Santis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-06-2024
- Paid Up Capital ₹ 0.10 M
as on 29-06-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 14.31%
(FY 2021)
- Profit 87.10%
(FY 2021)
- Ebitda 49.53%
(FY 2021)
- Net Worth -11.51%
(FY 2021)
- Total Assets 42.74%
(FY 2021)
About Santis Pharmaceuticals
The Corporate was formerly known as Vertis Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kosha Jha and Sanjaykumar Jha serve as directors at the Company.
- CIN/LLPIN
U24100GJ2010PTC060313
- Company No.
060313
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2010
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Santis Pharmaceuticals Private Limited offer?
Santis Pharmaceuticals Private Limited offers a wide range of products and services, including Vitamins & Supplements, Vitamins A-Z, Multivitamins.
Who are the key members and board of directors at Santis Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kosha Jha  | Additional Director | 09-Apr-2022 | Current |
| Sanjaykumar Jha | Director | 19-Apr-2010 | Current |
Financial Performance of Santis Pharmaceuticals.
Santis Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 14.31% increase. The company also saw a substantial improvement in profitability, with a 87.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Santis Pharmaceuticals?
In 2021, Santis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Expert Second Opinion Services Private LimitedActive 3 years 2 monthsSanjaykumar Jha is a mutual person
Salvavita Pharmaceuticals Private LimitedActive 3 years 11 monthsSanjaykumar Jha is a mutual person
Emzor Exports Private LimitedActive 17 years 7 monthsKosha Jha and Sanjaykumar Jha are mutual person
- Santis Hospital And Research Institute Private LimitedActive 3 years 7 months
Kosha Jha and Sanjaykumar Jha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Santis Pharmaceuticals?
Santis Pharmaceuticals has a workforce of 105 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Santis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Santis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
